A US government advisor warned officials of the dangers of antibiotic-resistant anthrax while profiting from antitoxin sales.
Advertisement
The Scientist
Most Recent
Researchers use a protein-lipid complex found in human breast milk to increase the activity of otherwise-ineffective antibiotics against drug-resistant pathogens.
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.
Systems biologist Lone Gram describes her approach to combing the oceans for novel compounds that may be useful in the fight against pathogens.
A normally land-based microbiologist sets sail to find the building blocks of novel antibiotics in marine bacteria.
Doctors turn to good microbes to fight disease. Will the same strategy work with crops?
Long-term exposure to antibiotics from agricultural run off may encourage the evolution of soil bacteria that break down and consume the antibacterial agents.
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
A river system in Colorado contains high concentrations of antibiotic resistance genes in areas close to water-treatment plants.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
